Francesca Barone

Insider Reports History

Entity
Individual
Location
Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham, MA
Signature
/s/ Charles Schoch, as Attorney-in-Fact for Francesca Barone
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Francesca Barone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Scientific Officer Common Stock 96.5K $846K $8.76 Mar 18, 2025 Direct
Candel Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 30.8K Mar 18, 2025 Direct

Insider Reports Filed by Francesca Barone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. Mar 18, 2025 3 -$254K 4 Mar 20, 2025 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Feb 12, 2025 1 $0 4 Feb 14, 2025 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Jan 15, 2025 1 -$97.8K 4 Jan 17, 2025 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Jan 8, 2025 1 -$112K 4 Jan 10, 2025 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Nov 29, 2024 1 -$101K 4 Dec 3, 2024 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Jul 17, 2024 1 -$90.9K 4 Jul 19, 2024 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Jul 11, 2024 1 -$75.5K 4 Jul 15, 2024 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Nov 28, 2023 1 -$17.8K 4 Nov 30, 2023 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Nov 26, 2023 1 $0 4 Nov 28, 2023 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Apr 28, 2023 1 $0 4 May 2, 2023 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Dec 8, 2022 1 $1.99K 4 Dec 12, 2022 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Nov 28, 2022 1 $0 4 Nov 30, 2022 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Feb 28, 2022 1 $0 4 Mar 1, 2022 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Feb 3, 2022 1 $0 4 Feb 7, 2022 Chief Scientific Officer
CADL Candel Therapeutics, Inc. Feb 3, 2022 0 $0 3 Feb 7, 2022 Chief Scientific Officer